♀* | ♂* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Pramex1−, Pramel1− | Pramel1+, Y | Pramex1−, Pramel1+ | Pramel1−, Y | Total | ||||||
Actual | Expected | Actual | Expected | Actual | Expected | Actual | Expected | Actual | Expected | |
Pramex1−, Pramel1− | 0 (0%) | 18.5 (6.25%) | 18 (6.08%) | 18.5 (6.25%) | 15 (5.07%) | 18.5 (6.25%) | 4 (1.35%) | 18.5 (6.25%) | 37 (12.5%) | 74 (25%) |
Pramex1+, Pramel1+ | 20 (6.76%) | 18.5 (6.25%) | 30 (10.14%) | 18.5 (6.25%) | 27 (9.12%) | 18.5 (6.25%) | 20 (6.76%) | 18.5 (6.25%) | 97 (32.77%) | 74 (25%) |
Pramex1−, Pramel1+ | 16 (5.41%) | 18.5 (6.25%) | 23 (7.77%) | 18.5 (6.25%) | 25 (8.45%) | 18.5 (6.25%) | 17 (5.74%) | 18.5 (6.25%) | 81 (27.36%) | 74 (25%) |
Pramex1+, Pramel1− | 14 (4.73%) | 18.5 (6.25%) | 21 (7.09%) | 18.5 (6.25%) | 28 (9.46%) | 18.5 (6.25%) | 18 (6.08%) | 18.5 (6.25%) | 81 (27.36%) | 74 (25%) |
Total | 50 (16.89%) | 74 (25%) | 92 (31.08%) | 74 (25%) | 95 (32.09%) | 74 (25%) | 59 (19.93%) | 74 (25%) | 296 (100%) | NA |